The influences of age and co-morbidities on treatment decisions for patients with HER2-positive early breast cancer

Critical Reviews in Oncology/Hematology

Volumn 76, Issue 2, 2010, Pages 127-132

  Ring, Alistair ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Breast cancer; Geriatric oncology; Trastuzumab

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; AGING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CLINICAL ARTICLE; CLINICAL DECISION MAKING; COMORBIDITY; CONTROLLED STUDY; DRUG INDICATION; EARLY CANCER; HIGH RISK PATIENT; HUMAN; ONCOLOGY; PATIENT REFERRAL; PRESCRIPTION; REVIEW; SURGEON; TREATMENT PLANNING; TUMOR VOLUME;

AGE FACTORS; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMORBIDITY; DATA COLLECTION; FEMALE; GENES, ERBB-2; HUMANS; MEDICAL ONCOLOGY; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; REFERRAL AND CONSULTATION;

EID: 77957923670     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2010.01.002     Document Type: Review

References (12)

1. Khaw K.T. How many, how old, how soon?. BMJ 1999, 319:1350-1352.
2. Ries LAG, Harkins D, Krapcho M, et al. National Cancer Institute. SEER cancer statistics review 2000-2003. Available at: Accessed 27 March 2009. http://seer.cancer.gov/csr/1975_2003/results_merged/topic_age_dist.pdf.
3. Early Breast Cancer Trialists' Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717.
4. Wildiers H., Kunkler I., Biganzoli L., et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2007, 8:1101-1115.
5. Giordano S.H., Duan Z., Kuo Y.F., Hortobagyi G.N., Goodwin J.S. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 2006, 24:2750-2756.
6. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182.
7. Hurst J.W., Morris D.C., Alexander R.W. The use of the New York Heart Association's classification of cardiovascular disease as part of the patient's complete Problem List. Clin Cardiol 1999, 22:385-390.
8. Juster F.T. Consumer buying intentions and purchase probability: an experiment in survey design. J. Am. Stat. Assoc. 1966, 61:658-696.
9. Brennan M., Esselmont D. The accuracy of the Juster Scale for predicting purchase rates of branded, fast-moving consumer goods. Market Bull 1994, 5:47-52. 9.
10. Green P.E., Wind J., Rao V.R. Conjoint analysis: methods and applications. The technology management handbook 1999, CRC Press, pp. 12-65-12-72.
11. Current interim life tables: United Kingdom (2005-2007). Office for National Statistics. Available at: Accessed 27 March 2009. http://www.statistics.gov.uk/downloads/theme_population/Interim_Life/ILTGB0507Reg.xls.
12. Adjuvant Online; Accessed 8 April 2009. http://www.adjuvantonline.com/.